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Successful development of safe and highly effective nanoprobes for targeted imaging of in vivo early gastric cancer
is a great challenge. Herein, we choose the CdSe/ZnS (core-shell) quantum dots (QDs) as prototypical materials,
synthesized one kind of a new amphiphilic polymer including dentate-like alkyl chains and multiple carboxyl
groups, and then used the prepared amphiphilic polymer to modify QDs. The resultant amphiphilic polymer
engineered QDs (PQDs) were conjugated with BRCAA1 and Her2 monoclonal antibody, and prepared BRCAA1
antibody- and Her2 antibody-conjugated QDs were used for in vitro MGC803 cell labeling and in vivo targeted
imaging of gastric cancer cells. Results showed that the PQDs exhibited good water solubility, strong
photoluminescence (PL) intensity, and good biocompatibility. BRCAA1 antibody- and Her2 antibody-conjugated
QD nanoprobes successfully realized targeted imaging of in vivo gastric cancer MGC803 cells. In conclusion, BRCAA1
antibody- and Her2 antibody-conjugated PQDs have great potential in applications such as single cell labeling and
in vivo tracking, and targeted imaging and therapeutic effects' evaluation of in vivo early gastric cancer cells in the
near future.
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Gastric cancer is the second most common cancer and
the third leading cause of cancer-related death in China
[1,2]. It remains very difficult to cure effectively, primarily
because most patients present with advanced diseases [3].
Therefore, how to recognize and track or kill early gastric
cancer cells is a great challenge for early diagnosis and
therapy of patients with gastric cancer.
We have tried to establish an early gastric cancer
prewarning and diagnosis system since 2005 [4,5]. We* Correspondence: dxcui@sjtu.edu.cn
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in any medium, provided the original work is phoped to find early gastric cancer cells in vivo by multi-
mode targeting imaging and serum biomarker detection
techniques [6-9]. Our previous studies showed that sub-
cutaneous and in situ gastric cancer tissues with 5 mm in
diameter could be recognized and treated by using multi-
functional nanoprobes such as BRCAA1-conjugated fluor-
escent magnetic nanoparticles, Her2 antibody-conjugated
RNase A-associated CdTe quantum dots, folic acid-conju-
gated upper conversion nanoparticles, RGD-conjugated
gold nanorods, Ce6-conjugated carbon dots, and Ce6-
conjugated Au nanoclusters (Au NCs) [10,11]. However,
clinical translation of these prepared nanoprobes is always
confounded by their in vivo biosafety. Development of safe
and highly effective nanoprobes for targeted imaging and
tracking of in vivo early gastric cancer cells has become
our concern.en Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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subjected to intensive investigations because of their
unique photoluminescence properties and potential
applications. So far, quantum dots have been used success-
fully in cellular imaging [12,13], immunoassays [14], DNA
hybridization [15,16], and optical barcoding [17]. Quantum
dots also have been used to study the interaction between
protein molecules or to detect the dynamic course of signal
transduction in live cells by fluorescence resonance energy
transfer (FRET) [18,19]. These synthesized quantum dots
have significant advantages over traditional fluorescent
dyes, including better stability, stronger fluorescence inten-
sity, and different colors, which are adjusted by controlling
the size of the dots [20]. Therefore, quantum dots provide
a new functional platform for bioanalytical sciences and
molecular imaging. However, some studies also showed
that some kinds of quantum dots exhibited toxic effects
such as cytotoxicity, tissue toxicity, and in vivo residues
[21,22]. How to develop safe quantum dots has become
the concern of many scientists.
In our previous work, we also synthesized safe quantum
dots such as Ag2S and AgSe [23,24] and used them forFigure 1 Scheme of synthesis of CdSe/ZnS QDs, amphiphilic polymer
synthesis of CdSe/ZnS QDs in high temperature and cosolvent. (b) Synthes
transfer of QDs from hydrophobic phase to hydrophilic phase by stirring an
PQDs by EDC. (e) Single molecule labeling and cell imaging with PQDs in
and in vivo.in vitro cell labeling and targeted imaging of in vivo gastric
cancer cells. However, their fluorescence signals are too
weak to be used for long-time imaging and single cell
tracking [25]. How to prepare safe quantum dots with
strong fluorescence signals has become a great challenge.
In this study, as shown in Figure 1, we chose the
CdSe/ZnS (core-shell) quantum dots (QDs) as prototyp-
ical materials, synthesized one kind of a new type of amphi-
philic polymer including dentate-like alkyl chains and
multiple carboxyl groups, and then used the prepared
amphiphilic polymer to modify QDs. The resultant amphi-
philic polymer engineered QDs (PQDs) were conjugated
with BRCAA1 monoclonal antibody and Her2 antibody,
and prepared BRCAA1 antibody- and Her2 antibody-
conjugated QDs were used for in vitro labeling and in vivo
targeted imaging of gastric cancer cells. Results showed
that the amphiphilic PQDs exhibited good water solu-
bility, strong photoluminescence (PL) intensity, and good
biocompatibility. BRCAA1 antibody- and Her2 antibody-
conjugated QD nanoprobes can specifically label gastric
cancer MGC803 cells and realize targeted imaging of gas-
tric cancer cells in vivo successfully., and coating process and their biological applications. (a) Typical
is of amphiphilic polymer: cross-linking PAA and OA by EDC. (c) Phase
d sonication. (d) Reaction scheme for coupling targeting antibody to
vitro. (f) General labeled cancer cell with PQDs for imaging in vitro
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Cadmium oxide (CdO, AR), stearic acid (98%), selenium
powder, octylamine (OA, 99%), 1-hexadecylamine (HAD,
90%), and diethylzinc (ZnEt2) were obtained from Aladdin
Co., Ltd. (Xi'an, China). Trioctylphosphine oxide (TOPO,
98%), trioctylphosphine (TOP, 95%), poly(acrylic acid)
(PAA, molecular weight (MW) 1,800), 1-ethyl-3-[3-dime-
thylaminoporpyl] carbodiimide hydrochloride (EDC, 98.5%),
and N-hydroxysuccinimide (NHS, 98%) were obtained from
Sigma-Aldrich Co., Ltd. (St. Louis, MO, USA). Bovine serum
albumin (BSA, 99.9%) was purchased from MP Biomedicals
Company (Santa Ana, CA, USA). Bis(trimethylsilyl) sulfide
((TMS)2S) was purchased from Tokyo Chemical Industry
Co., Ltd. (Tokyo, Japan). Liquid paraffin, chloroform,
ethanol, hydrochloric acid (HCl), 2-(4-morpholino)ethane-
sulfonic acid (MES), N,N-dimethylformamide (DMF),
paraformaldehyde, and Tween-20 were purchased from
Sinopharm Chemical Regent Co., Ltd. (Shanghai, China).
Synthesis of CdSe and CdSe/ZnS core-shell QDs
Highly luminescent core-shell CdSe/ZnS QDs were pre-
pared in high temperature via the pyrolysis of organometal-
lic reagents in a coordinating solvent [26-28]. We select
200°C with and without HAD for synthesis of green- and
red-emitting CdSe QDs. The molar ratio of CdO/Se/stearic
acid in liquid paraffin was 1:1:4, and the crude QD products
were purified by chloroform and ethanol. For the ZnS shell,
equal molar ratios of (TMS)2S and ZnEt2 as precursors of
Zn and S, and TOP/TOPO were used, and 90°C was used
for shell growth. The final core-shell product was re-
purified and redispersed into aliquot chloroform for
later use. About 10 ml of deionized water was added
to the solution to prevent evaporation of chloroform
for long-period storage (see Additional file 1 for synthesis
details of QDs).
Synthesis and characterization of amphiphilic polymer
The amphiphilic polymer is synthesized as follows: in
ambient temperature, 0.2 g of PAA (MW 1,800) was
added to a flask containing 10 ml DMF. Under slight stir-
ring for 1 h, 137 μl of OA was added, and the solution
was continuously stirred for another 30 min. In an indi-
vidual vial, 0.47 g EDC was dissolved in 0.5 ml DMF and
injected to the reaction solution dropwisely. The reaction
solution was mixed vigorously overnight to produce
amphiphilic polymers (with 50% of the carboxylic acid
functional groups modified with an aliphatic chain). Next,
0.25 M HCl was added drop by drop to the polymer
solution under vigorous stirring, resulting in a milky and
opaque colloid solution. The colloid was centrifuged at
8,000 rpm/min for 10 min. The supernatant was discarded,
and the jelly-like precipitant was washed with 0.25 M HCl
twice to remove any by-products and impurities. The finalprecipitate was collected and freeze dried to remove trace
amounts of water, giving a dry, white powder. Fourier trans-
form infrared (FTIR) spectroscopy (Equinox 55, Bruker,
Karlsruhe, Germany) was used to verify the formation of
amide bond and carboxylic groups.
Preparation and characterization of amphiphilic polymers
conjugated with QDs
An aliquot of amphiphilic polymer powder was resus-
pended in MES buffer (0.1 mol/l, pH 6.0) for later use.
As-prepared QDs (200 μl, 0.15 mmol) dissolved in chloro-
form and amphiphilic polymer solution (2.0 ml, 0.45 mmol)
were added to 8 ml of deionized water in an open con-
tainer. The solution was stirred and sonicated for 30 min
until the chloroform evaporated completely in the final
products. Afterward, the hydrated colloid (polymer-coated
QDs, PQDs) was further purified by size exclusion
chromatography (Superdex 75, Pharmacia Biotech, AB,
Uppsala, Sweden), yielding a transparent, homogeneous,
and strong fluorescent solution.
After purification, the purified solution was then con-
centrated under reduced pressure using a rotary evapor-
ator at approximately 15°C. For assessment of the size
distribution and monodispersity of the PQDs, the primal
QDs of CdSe, CdSe/ZnS, and purified PQDs were pipetted
onto a carbon transmission electron microscopy (TEM)
grid; the solvents were wicked away slowly after 15 min.
For the PQDs, the grids were counterstained with a 1%
phosphotungstic acid solution (pH adjusted to 6) for 30 s.
The staining solution was wicked away similarly. All of the
prepared grids were imaged (TEM, JEM-2100 F system,
JEOL Ltd., Tokyo, Japan) and compared to determine size
distribution of the QDs and the degree of polymer coating.
For further size analysis, the as-prepared QDs and PQDs
were measured using Zetasizer Nano ZSP (Malvern Instru-
ments, Ltd., Worcestershire, UK). In addition, the optical
properties of the prepared CdSe, CdSe/ZnS, and PQDs
were measured using UV-visible and fluorescence spectro-
photometer (Cary 50 Conc, Varian, Palo Alto, CA, USA; F-
4600, Hitachi, Tokyo, Japan). The QD concentration was
determined using Beer's law after measuring the absorb-
ance value using spectrophotometry [29,30].
In order to estimate the surface charge and functional
group character, we further characterized the polymer and
PQDs by using 1% agarose gel electrophoresis. The agarose
gel was prepared using standard techniques, and the pre-
pared polymer and PQDs were added into the loading well.
The gel was run in 0.5× TBE buffer (pH 8.0) for 30 min at
100 V and imaged with Tanon 2500 gel imaging system
(Tanon, Shanghai, China) under 365-nm exciting light.
Afterward, the gel was stained with lead acetate (1%) and
potassium chromate (1%) for 5 min, respectively, and im-
aged in the Tanon 2500 system with white light to visualize
the carboxyl group contained in the amphiphilic polymer.
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to validate the success of QDs' surface coating.
Effects of pH and ionic strength on the stability of PQDs
In order to evaluate the effects of a wide pH range and
high salt concentration on the colloidal stability of the
PQDs, the PQD colloids were dispersed in varied pH
buffers, PQDs/buffer = 1:1 (v/v), and pH ranged from 2
to 13 (Additional file 1: details of preparation of a series
of buffer solutions). The resulting PL spectra were back-
ground-corrected, integrated, and normalized to the in-
tensity of PQDs in pH = 7, set as 100%. The stability
effect of ionic strength was carried out as follows: dis-
persions of PQDs were placed in fluorescence cuvettes
(1-cm optical path) containing an equal concentration of
PQDs but various concentrations of sodium chloride.
The lack of volumes was replenished with deionized water
(pH = 7). The PL emission from PQDs without NaCl
added was set to 100%. The resulting PL spectra were
normalized to the emission form slat-free solution.
Preparation of BRCAA1 antibody- and Her2
antibody-conjugated QD nanoprobes
The BRCAA1 monoclonal antibody was conjugated with
red PQDs, whereas humanized Her2 monoclonal antibody
was conjugated with green PQDs. The optimum mole
ratio of PQDs to antibody is 5:3 [31]. The cross-linking
reaction was done by using standard EDC-NHS procedure
in ambient temperature and dark place for 2 h with con-
tinuous mixing. The mixture was then purified by chrom-
atography (Superdex 75, Pharmacia Biotech, AB, Uppsala,
Sweden) to remove the free antibody residues. The result-
ant BRCAA1 antibody- and Her2 antibody-conjugated
PQDs were stored at 4°C for later use.
Afterward, the prepared PQDs and specific monoclonal
antibody conjunction were analyzed in 8% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE, Beyo-
time, Shanghai, China). The gel was run in a standard SDS
buffer for 90 min at 120 V. Firstly, the gel was imaged with
UV light to determine PQD position, and then, the gel was
stained with Coomassie Brilliant Blue fast staining solution
and imaged with white light to determine protein position.
The coupling rate of the PQDs and monoclonal antibody
was estimated by a NanoDrop device (Thermo Scientific,
Wilmington, DE, USA). Before coupling reaction, we
measured the total concentration of monoclonal anti-
body. After coupling reaction, we estimated the mono-
clonal antibody concentration in the eluenting phase of
chromatography and calculated the coupling rate accord-
ing to the following equation:Coupling rate %ð Þ ¼ 1−Concentration of monoclonal antibody ið
 100:BRCAA1 antibody- and Her2 antibody-conjugated QDs for
targeted imaging of MGC803 cells in vitro
The overnight incubated MGC803 and GES-1 cells were
fixed with 4% paraformaldehyde for 10 min and perme-
ated with 0.5% (v/v) Tween-20 for 20 min. Then, these
cells were blocked for 20 min in PBS containing 1% (w/v)
BSA. After being washed with PBS twice, these cells were
incubated at 4°C with BRCAA1 antibody- and Her2 anti-
body-conjugated QDs overnight. Unbound probes were
removed by washing three times with PBS. Afterward,
these cells were imaged under a fluorescence microscope
(TS100, ×400, Nikon Co., Tokyo, Japan) and laser scanning
confocal microscope in oil immersion objective (Nikon
A1si+, ×1,000).
After attaining the fluorescence images, the gastric
cancer cells were dissociated from the glass culture dish
and sectioned as routine for TEM imaging.
BRCAA1 antibody- and Her2 antibody-conjugated QDs for
targeted imaging of gastric cancer cells in vivo
To quantitatively analyze the fluorescence intensity from
PQD-labeled MGC803 cells, macro fluorescence images
were acquired using PQD-labeled MGC803 cells which
were diluted with PBS to a final concentration from 2 × 102
to 2,048 × 102 cells/200 μl. Afterward, 200 μl of the pre-
pared cell solutions were added to polystyrene TC-treated
96-well microplates (Corning® Life Sciences, Corning, NY,
USA, #3603). Fluorescence intensity was measured in a
Bruker In-Vivo F PRO system (Bruker Corporation, UK),
and the resulting background-corrected data was curve
fitted to single exponentials. Signal curve fitting was done
using the software Origin (OriginLab, Northampton, MA,
USA; http://www.originlab.com/).
All of the following animal studies complied with current
ethical considerations: Approval (SYXK-2007-0025) of the
Institutional Animal Care and Use Committee of Shanghai
JiaoTong University (Shanghai, China) was obtained. Nude
mice (male, 18 to 22 g, 4 to 5 weeks old) were obtained
from the Shanghai LAC Laboratory Animal Co. Ltd., Chinese
Academy of Sciences (Shanghai, China, SCXK2007-0005),
and housed in a SPF-grade animal center.
Pathogen-free athymic nude mice were housed in a
vivarium accredited by our University. Male athymic
nude mice (4 to 6 weeks old) were used to establish sub-
cutaneous gastric cancer models; 1.5 × 106 MGC803 cells
suspended in 100 μl DMEM were subcutaneously injected
into the left anterior flank area of each mouse. Four weeks
later, tumors were allowed to grow to approximately 5 mm
in diameter, and the prepared Her2 antibody-conjugated
QDs (red, emission peak 657 nm) were injected into then eluenting phase=Total concentration of monoclonal antibodyÞ
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ex vivo organ imaging were performed using the Bruker
In-Vivo F PRO system. The excitation and emission filters
were set to 410 and 700 nm (band pass, ±15 nm), respect-
ively, and exposure time was set to 3 s. Collected images
were analyzed using the imageJ software (NIH ImageJ;
http://rsb.info.nih.gov/ij/), which uses spectral unmixing
algorithms to separate autofluorescence from quantum
dot signals.
Results and discussion
Characterization of synthesized CdSe, CdSe/ZnS QDs,
and PQDs
Different from our previous reports [3,32], the liquid
paraffin and HDA were used as organic cosolvent to
prepare the core CdSe QDs in this study. As shown in
Figure 2a, synthesized QDs and PQDs exhibited strong
fluorescence signal and narrow emission spectra. The
emission peaks of synthesized CdSe, CdSe/ZnS, and PQDs
are shown in Table 1. Figure 2b showed a typical TEM
image of the CdSe core (reaction time 30 min, at 200°C).
The QDs are observed to be spherically shaped, compact,
and dense in structure, with a narrow diameter distribution
of 4.3 nm approximately. The inset high-resolution trans-
mission electron microscopy (HRTEM) image showed
well-developed lattice fringes of the synthesized coreFigure 2 Characteristics of synthesized CdSe, CdSe/ZnS, and amphiph
spectra of synthesized QDs. The green and red groups of lines represent ab
photoluminescence (the curves with obvious protrusive shape) of the QDs
dashed line, and dash-dot line indicate the core QDs, the core-shell structure
of CdSe/ZnS core-shell prepared from CdSe. (d) TEM image of amphiphilic po
phosphotungstic acid solution. Insets in (b) and (c) showed the HRTEM imagestructure. As shown in Figure 2c, the CdSe/ZnS QDs have
a narrow size distribution of 4.8 nm in diameter. The
existence of lattice planes on the HRTEM confirms the
good crystallinity of the CdSe/ZnS core-shell structure.
With the ZnS coating, the emission peak of CdSe/ZnS
was shifted to a longer wavelength compared to that of
the core, CdSe QDs (Table 1). The shell could not only
enhance the core's anti-oxide ability, but also improved its
stability and decreased the cytotoxicity [33-35]. The am-
phiphilic polymer-coated QDs were 5.4 nm in diameter
(Figure 2d), while following 12- and 11-nm blueshift of
the emission peak for red and green emission QDs, re-
spectively (Figure 2a and Table 1). The green-colored QDs
showed a similar TEM characterization with red emission
color QDs (data not show).
For biological application of QDs, the as-prepared core-
shell QDs should be further coated with amphiphilic
polymers or ligands that allow these nanomaterials to be
transferred from the organic phase to water phase [36].
Different with PEG and other sulfhydryl compound-
mediated aqueous solubility [37], in our experiments,
we synthesized the amphiphilic polymer containing a
dentate-like alkyl chain (hydrophobic) and the multiple
carboxyl groups (hydrophilic) inlaid in the long aliphatic
chains. The hydrophobic parts of the amphiphilic polymer
could interact with the alkyl chain that coated the QDilic polymer-coated QDs (PQDs). (a) The absorbance and emission
sorbance (the curves from upper left to lower-middle part) and the
at emission peaks of 526 and 644 nm, respectively. The solid line,
QDs, and PQDs, respectively. (b) TEM image of CdSe cores. (c) TEM image
lymer-coated CdSe/ZnS core-shell QDs counterstained with 1%
s of the core and core-shell QD. (b,c,d represent red-colored QDs).
Table 1 The emission peaks of synthesized CdSe, CdSe/ZnS,
and PQDs (nm)
Color CdSe core CdSe/ZnS core-shell PQDs
Green 526 549 538
Red 644 669 657
Li et al. Nanoscale Research Letters 2014, 9:244 Page 6 of 13
http://www.nanoscalereslett.com/content/9/1/244surface from TOPO; these two layers ‘bond’ to each other
and form a hydrophobic protective structure that resists
hydrolysis and enzymatic degradation even under com-
plex in vitro or in vivo conditions [38]. The hydrophilic
parts, in turn, are directed toward water and render the
colloidal stability. Besides imparting aqueous solubility
in a wide range of pH, the carboxyl groups can be used
for further coupling chemistry with biological mole-
cules or organic dyes such as carbodiimide (e.g., EDC)-
based cross-linking and endowed it with potential ap-
plications of single molecule labeling, cellular imaging,
or specific tissue mapping in clinical and biological
practice [39].
After a series of treatments were done as illustrated in
Figure 1, we examined dispersibility of the prepared
CdSe and CdSe/ZnS which were dissolved in chloroformFigure 3 Characteristics of synthesized QDs and PQDs (red). The size h
and (c) PQDs in MES buffer (pH = 6.0). (d) Electrophoretic images of synthe
365-nm UV lamp, and the right panel was taken in room light after staining
polymer; lane 2, PQDs). (e) SDS-PAGE results of PQDs (lane 1), antibody (BRand PQDs in MES buffer (pH = 6.0) using Zetasizer
Nano ZSP. Figure 3a,b,c shows histograms of size distri-
butions and aspect ratio from these synthesized samples
(core emission peak 644 nm). This figure shows size dis-
tribution histograms of as-synthesized QD samples with
an average size of (a) 4.3 ± 0.5 nm (CdSe in chloroform), (b)
4.8 ± 0.5 nm (CdSe/ZnS in chloroform), and (c) 5.4 ± 0.8 nm
(PQDs in MES buffer).
The FTIR spectrum of the primary CdSe, CdSe/ZnS,
and PQDs shows that (Additional file 1: Figure S1,
details of FTIR) the peak of CdSe at 2,760 ~ 2,930 cm−1
is the characteristic symmetric and asymmetric methy-
lene stretching (vC-H) that comes from the cosolvent ma-
terial used in synthesis [40] (Additional file 1: Figure S1a).
In the FTIR spectrum of CdSe/ZnS QDs (Additional
file 1: Figure S1b), the peak at 1,183 cm−1 is the charac-
teristic symmetric and asymmetric stretching vibrations
from TOPO (vP=O) [37,41]. After transferring from the
hydrophobic phase to the hydrophilic phase, for PQDs
(Additional file 1: Figure S1c), many peaks emerged. The
peak at 1,728 cm−1 is the vibration from C =O of the
synthesized polymer (vC =O), and the peaks emerging at
1,609 and 1,310 cm−1 are the characteristic asymmetric
and symmetric stretching vibrations from COO− groupsistograms of synthesized (a) CdSe and (b) CdSe/ZnS in chloroform
sized amphiphilic polymer and PQDs. The left panel was taken under
with lead acetate and potassium chromate (lane 1, amphiphilic
CAA1, lane 2), and PQD-antibody conjugates (lane 3).
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of these QDs is an excellent evidence to prove that
the PQDs had been successfully modified by the amphi-
philic polymer.
Figure 3d shows a comparison of the mobility shift of
the amphiphilic polymer and 657-nm-emitting PQDs
capped with the amphiphilic polymer. After 30 min of
electrophoresis, the amphiphilic polymer cannot been
seen in this UV condition (Figure 3d, left panel, lane 1).
Meanwhile, the PQDs show a bright and narrow pre-
dominant band under the 365-nm UV light (Figure 3d, left
panel, lane 2). This suggests that the synthesized PQDs
are homogeneous. Afterward, the gel was stained with
lead acetate and potassium chromate, and the carboxyl
group was stained with lead chromate and had a dark
yellow color. Under room light, the amphiphilic polymer
and PQD (containing carboxyl groups) migrations can be
seen clearly (Figure 3d, right panel).
Stability of synthesized PQDs
In order to verify the long-term colloidal stability of
the PQDs, we tested the PQD stability by a wide-range
pH value. The images in Figure 4a show the relative
photoluminescence intensity and fluorescence image ofFigure 4 Stability of synthesized PQDs in various pH values and diffe
623-nm-emitting PQDs. PQD colloids were dispersed in varied buffers, pH 2
on the photoluminescence of PQDs. The final sodium chloride concentratio657-nm-emitting PQDs in various pH values (the PL
intensity in pH = 7 as the reference, 100%). We found that
the strongly acidic condition (pH 4 or lower) rapidly led
to a partial or complete fluorescence quenching of the
PQDs, but no obvious agglomerate has been found. We
surmise that this strongly acidic environment neutralized
the surface negative charge of PQDs, resulting in agglom-
erate invisible to the naked eyes. The remaining PQDs
were stable in weakly acidic to strongly basic pH condi-
tions (pH 5 ~ 6 to approximately 13) without apparent
fluorescence quenching for at least a 3-month period
(Additional file 1: Figure S2, PL images of PQDs in differ-
ent pH buffer with increasing span of time). We note that
the pH stability of the present PQDs is comparable to that
of QDs coated with DHLA or PMAA ligands [27,39,43]
and is excellent, and our PQD preparation procedure pos-
sesses fewer steps and is more convenient for the synthesis
of amphiphilic polymer and phase transfer.
In addition to the pH stability, we investigated the
behavior of the PQDs in aqueous solutions with different
ionic strengths. In the experiment, the PL properties of
PQDs dispersed in PB buffer solutions at neutral pH were
monitored, with NaCl concentration increased from 0
to 300 mM. Over the concentration range of NaCl, werent ionic strengths. (a) Effect of pH on the photoluminescence of
~ 13, PQDs/buffer = 1:1 (v/v). (b) Influence of increasing ionic strength
ns varied from 0 to 300 mM (pH = 7.4).
Figure 5 The MTT analysis results of MGC803 and GES-1 with
and without PQD labeling.














1 10,000.0 2,204 77.96 10,000.0 2,582 74.18
2 10,000.0 2,749 72.51 10,000.0 2,865 71.35
3 10,000.0 2,566 74.34 10,000.0 2,773 72.27
4 10,000.0 2,177 78.23 10,000.0 2,309 76.91
5 10,000.0 2,545 74.55 10,000.0 2,785 72.15
Average 75.52 73.37
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the emission spectra for PQDs (Figure 4b, the PL intensity
without NaCl added was set to 100%). This result is very
similar with the previous reports [44,45]. These results of
pH and ionic strength stability further highlight that the
PQDs may be completely tolerant to intracellular and
in vivo environments, where the ionic concentration is
known to be less than 150 mM [46].
The efficiency of PQDs conjugated with antibody
The prepared PQDs and PQD-antibody probe characteris-
tics were assessed by 8% polyacrylamide gel electrophor-
esis (SDS-PAGE) [47]. In this experiment, the synthesized
PQDs, monoclonal antibody, and PQD-antibody conjuga-
tion were added to specimen insertion ports, named lanes
1, 2, and 3, respectively. To avoid the acidic quenching
effect on PQDs (the destaining solution contains acetic
acid, based on the anterior results), after running with
SDS buffer for 90 min, the gel was imaged on the Tanon
2500 gel imaging system with UV light (365 nm) in
advance. To validate the coupling reaction, the gel was
stained with Coomassie Brilliant Blue fast staining solu-
tion and washed with destaining solution. The stained gel
was imaged again in white light. A comparison of the UV
image with the image obtained by staining with Coomassie
Blue is shown in Figure 3e. Apparently, in lane 1, the PQDs
showed a clear bond which cannot be seen in bright fields
(Figure 3e, left and right panels, lane 1). For monoclonal
antibody, no signal can be detected in UV light but it is
fairly visible in bright fields (Figure 3e, left and right panel,
lane 2). However, in the conjugation of PQD-antibody, the
band clearly can be seen both in UV light and bright fields;
both of the migration ratios in different imaging conditions
are identical (Figure 3e, left and right panels, lane 3). This
result suggested that the conjugation between monoclonal
antibody and PQDs is successful.
The mean coupling rates of BRCAA1 and Her2 were
75.52% and 73.37%, respectively, as shown in Table 2.
Effects of PQDs on cellular viability
In order to evaluate the influence of PQDs to living cells
(MGC803 and GES-1), the labeled cells (non-specificlabeling by endocytosis) were passaged parallel with the
original cells (non-labeled). In each passage, the fissional
and developmental abilities of these cells were estimated
by MTT assay (repeated three times). Compared with
the MTT results of PQD-labeled cells and the original
cells, almost identical MTT values were gained in each
generation (Figure 5). This consequence confirmed that
the synthesized PQDs have negligible toxicity to the
labeled cells and this is the essential requirement for
further clinical applications [48,49].
BRCAA1 monoclonal antibody-conjugated QDs for in vitro
targeted imaging
BRCAA1 antigen is a specific protein for the intracellular
epitope of histone deacetylase complex subunit SAP180
expressed in the cytoplasm of the breast cancer cell line
MCF-7 and gastric cancer cell line MGC803 [3]. More-
over, several research results confirmed the overexpression
of Her2 in gastric cancer and some other aggressive
disease [50]. Therefore, we choose these two monoclonal
antibodies (BRCAA1 conjugate to red PQDs and Her2
conjugate to green PQDs) as single molecular probes to
image gastric cancer cells. In addition, because both ex-
pressing (MGC803 cell) and non-expressing (GES-1 cell)
cells can be simultaneously visualized in a given
Figure 7 Confocal micrographs of MGC803 cell target-labeled with the BRCAA1-antibody PQD probes. (a) Bright field, (b) cytoplasm
labeled by PQDs, (c) nucleus stained by DAPI, (d) cosituated picture of cells and fluorescence. (a-d) Scale bars are 25 μm. (e) Z/X- and Z/Y-sections
reconstructed from a confocal series through representative cells. (f) Three-dimensional reconstruction of representative cells. (e-f) Scale bar represents
5 μm. Fourteen sections of 990 nm were taken for each series, and Z-sections were reconstructed with Imaris™ software. Z-sections were taken at a
line running through the midpoint of the XY plane.
Figure 6 PQD-antibody probes for targeted imaging of in vitro MGC803 cells. (a-d) Bright-field and fluorescence images of gastric cancer
MGC803 cell line; the cells were incubated at 4°C with PQD-antibody probes (BRCAA1 and Her2) in 1% BSA overnight (similarly hereinafter),
excited with 450 and 510 nm for Her2 and BRCAA1 probes, respectively, and exposure time was 15 s. (e-h) Bright-field and fluorescence images
of human fetal gastric epithelial GES-1 cell line; fluorescence exposure time was 60 s. Scale bars are 25 μm.
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serve as a good control [51].
The targeted imaging results are shown in Figure 6.
Each bright-field image shows multiple cells (Figure 6a,e),
but only MGC803 cells expressing specific protein (anti-
gen) of BRCAA1 and Her2 were labeled with PQD-anti-
BRCAA1 (red) and PQD-anti-Her2 (green) probes and
presented evenly fluorescent signal in the cytoplasm
(BRCAA1) and membrane (Her2) (Figure 6b,c,d). In the
GES-1 cell without expression of BRCAA1 and Her2
antigens, very weak or no apparent signals were detected
(Figure 6f,g,h). This result indicated that the synthesized
PQD-antibody probes are relatively specific for the estab-
lished targets. This correlation demonstrates that the sin-
gle molecule expressed in the intracellular environment or
membrane can be targeted and imaged by PQD-antibody
probes. This approach can thus be extended to specifically
label target proteins or cell types to visualize their interac-
tions in fixed cells and pathological sections.
To confirm the application of the prepared PQD-
antibody probe for gastric cancer cell imaging, the gastric
cancer MGC803 cell was labeled with the PQD-anti-
BRCAA1 probe as mentioned above. Then, the cell was
observed by confocal laser microscopy. Figure 7 shows
that the cytoplasma was evenly labeled by the PQD-anti-Figure 8 TEM images of endocytosis of PQDs and single molecule lab
images of general labeling with PQDs; the red circles enclose PQD granules e
with synthesized PQD-antibody probes; the blue arrows pointed out the evenBRCAA1 probe to red (Figure 7b) and the cell nuclei were
stained by DAPI to blue (Figure 7c). By means of Z/X-
and Z/Y-sections constructed from the confocal series,
it can be seen that the synthesized PQDs were homo-
geneously distributed in the cell cytoplasma (Figure 7e).
Furthermore, the three-dimensional reconstruction of
representative cells showed that the PQDs were pre-
dominantly distributed in the cytoplasm and not the
nucleus because the BRCAA1 protein was expressed
mainly in the cytoplasm (Figure 7f ). These results in-
dicated that the synthesized PQD-anti-BRCAA1 probe
could penetrate the cellular membrane and bind with
the protein molecule expressed in the cytoplasm of
the MGC803 cell. Additionally, these fluorescence images
also further elucidated that the synthesized PQD-
antibody probes could target label the single molecule
expressed in the gastric cancer MGC803 cell line
efficiently.
We also examined the endocytosis of PQDs and pre-
pared nanoprobes such as BRCAA1 antibody-PQDs in
MGC803 cells. In endocytosis, the PQDs were distributed
in the cytoplasm as granules and colocalized almost com-
pletely in endocytic vesicles (red circles in Figure 8a,c);
this indicates that the PQDs were internalized by endo-
cytosis pathway. Regarding targeted labeling, the BRCAA1eling with PQD-antibody probes in MGC803 cell. (a, c) TEM
ndocytosed by MGC803 cells. (b, d) Targeted single molecule labeling
ly distributed biomolecule probes in the cytoplasm of the MGC803 cell.
Figure 9 Sensitivity and capability of PQDs (red)-labeled MGC803 cell imaging in live animals. (a, b) The quantitative analysis of
fluorescence of PQD-labeled MGC803 cells showed a linear relationship (R2 = 0.98777) between fluorescence intensity and cell numbers.
(c) Fluorescence imaging of different amounts of PQD-labeled MGC803 cells injected subcutaneously in a mouse (cell numbers of 32× 102, 128×
102, 512× 102, and 2,048 × 102 corresponded to the sites 1, 2, 3, and 4 marked in the image; excitation filter 410 nm, emission filter 700 ± 15 nm,
band pass).
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plasm (blue arrows in Figure 8b,d), and this was consistent
with microscopic and confocal images mentioned above.
The TEM images certified that the synthesized PQD-
antibody probes can target and image the MGC803 cell
specially.Figure 10 Targeted imaging of gastric cancer in nude mice model by
model loaded with MGC803 cells and control mouse. (b) Targeted imaging
signal of in vivo gastric cancer (pseudocolor). (d) Colocalization image of bBRCAA1 monoclonal antibody-conjugated QDs for in vivo
targeted imaging
For in vivo imaging, it is important to estimate the
parameters of fluorescence intensity and the labeled
cells; after that, the optimum number of the labeled cells
can be decided for in vivo imaging. From Figure 9a,b, weBRCAA1 monoclonal antibody-conjugated QDs. (a) Nude mouse
of in vivo gastric cancer under dark visual field. (c) The fluorescence
right field and fluorescence signal.
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of PQD (red)-labeled MGC803 cells from 2 × 102 up to
2,048 × 102, but the system appears to become saturated
when greater numbers of cells are introduced.
As shown in Figure 9c, after subcutaneous injection of
different amounts of PQD-labeled MGC803 cells in the
athymic nude mouse, the fluorescence signals were ob-
served in the injection sites and there was a steady
increase of the fluorescence intensity in the injection
sites with the increment of PQD-labeled MGC803 cells.
As can be seen in injection site 1, merely 32 × 102 PQD-
labeled cells could provide a significant fluorescence
signal. The fluorescence signal of in vivo imaging
shows that MGC803 cells were successfully labeled
with PQDs.
After BRCAA1-antibody-conjugated PQD nanoprobes
were injected into nude mice via the tail vein for 24 h,
as shown in Figure 10, most of the prepared QD nanop-
robes accumulated in the tumor site. This result showed
that the synthesized nanoprobes can be successfully used
for targeted imaging of in vivo gastric cancer in gastric
cancer-bearing nude mice models.Conclusion
In conclusion, BRCAA1 monoclonal antibody- and Her2
antibody-conjugated amphiphilic polymer-modified core-
shell CdSe/ZnS quantum dots were successfully prepared,
exhibited good biocompatibility and strong stable fluo-
rescence signals, and were successfully used for in vitro
and in vivo targeted imaging of gastric cancer MGC803
cells. High-performance BRCAA1 antibody- and Her2
antibody-conjugated amphiphilic polymer-modified core-
shell CdSe/ZnS quantum dot nanoprobes exhibit great
potential in applications such as molecular imaging and
therapeutic effect evaluation of early gastric cancer in the
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